You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康健國際醫療(03886.HK)中期扭虧為盈 營收超9億港元同比增長28.97%
格隆匯 08-25 23:42

格隆匯8月25日丨康健國際醫療(03886.HK)公佈中期業績,截至2023年6月30日止六個月,公司收入為9.17億港元,同比增長28.97%;公司擁有人應占期內溢利為2106.1萬港元,去年同期則虧損為2533.7萬港元,實現扭虧為盈。

公吿稱,收入增加主要歸因於(a)對香港的醫療服務及醫療網絡管理以及中國內地醫院管理及醫療服務的需求增加;及(b) Central Medical Holdings Limited於2022年8月被集團收購後的貢獻。

於2023年6月30日,集團擁有417個涵蓋多個科目的醫療服務點,包括240個普通科服務點、67個專科服務點、20個牙科服務點,以及90個輔助服務點。於2023年6月30日,集團共有792名醫生、牙醫及輔助服務人員(包括394名普通科醫生、235名專科醫生、32名牙醫及131名輔助服務人員),通過集團旗下自營及聯營的醫療服務中心網絡提供醫療服務。

公吿稱,集團作為擁有強大專業醫療團隊和豐富優質醫療資源的行業翹楚,將順應經濟情況變化及醫療行業發展趨勢,適時調整業務策略以持續發展業務。未來,集團將進一步整合現有醫療資源,搭建跨境綜合醫療保健服務生態圈,滿足客户從預防、診斷、門診、住院、復康、護理、送藥等的全方位需求。集團致力建設紮根香港、立足灣區、服務全國、連通世界的國際一流醫療集團,力求持續為客户及股東創造更大價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account